相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study
Mireia Gausachs et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors
Cathrin Huth et al.
MODERN PATHOLOGY (2012)
Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion
Henry T. Lynch et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Alu in Lynch Syndrome: A Danger SINE?
Megan P. Hitchins et al.
CANCER PREVENTION RESEARCH (2011)
Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH
Carles Garcia-Linares et al.
HUMAN MUTATION (2011)
Recurrence and Variability of Germline EPCAM Deletions in Lynch Syndrome
Roland P. Kuiper et al.
HUMAN MUTATION (2011)
Analysis of EPCAM Protein Expression in Diagnostics of Lynch Syndrome
Matthias Kloor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome
Monika Morak et al.
JOURNAL OF MEDICAL GENETICS (2011)
Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
Kandelaria Rumilla et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Marlies J. E. Kempers et al.
LANCET ONCOLOGY (2011)
Somatic Hypermethylation of MSH2 Is a Frequent Event in Lynch Syndrome Colorectal Cancers
Takeshi Nagasaka et al.
CANCER RESEARCH (2010)
Deletions Removing the Last Exon of TACSTD1 Constitute a Distinct Class of Mutations Predisposing to Lynch Syndrome
Marietta E. Kovacs et al.
HUMAN MUTATION (2009)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas
Marjo van Puijenbroek et al.
FAMILIAL CANCER (2008)
RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference
J. Etzler et al.
HUMAN MUTATION (2008)
High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas
A. Middeldorp et al.
JOURNAL OF PATHOLOGY (2008)
Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer
H. Ogiwara et al.
ONCOGENE (2008)
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
H. F. A. Vasen et al.
JOURNAL OF MEDICAL GENETICS (2007)
Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients
M. Spaepen et al.
FAMILIAL CANCER (2006)
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary Nonpolyposis colorectal cancer (HNPCC)
H van der Klift et al.
GENES CHROMOSOMES & CANCER (2005)
The 5′ Region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences
FC Charbonnier et al.
HUMAN MUTATION (2005)
Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
H Hampel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]
HFA Vasen
FAMILIAL CANCER (2005)
分享论文
